Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized...

Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf...

November 27th, 2018

G1 Therapeutics Releases Phase 2 Data

Trilaciclib was tested in combination with chemotherapy and the checkpoint inhibitor Tecentriq in first-line small cell...

November 27th, 2018

Loxo Receives FDA Drug Approval

The patients eligible for this treatment have few alternative options and represent a high-risk morbidity for...

November 27th, 2018

Chi-Med and Eli Lilly Launch Elunate in China

The drug is available in capsule form to treat metastatic colorectal cancer for patients that have...

November 26th, 2018

Genentech’s Venclexta Receives New FDA Approval

As per the announcement, the FDA has given Venclexta accelerated approval for newly diagnosed acute myeloid...

November 22nd, 2018

Transdermal Delivery Technology Improving Bioavailability in Cannabinoid Therapeutics

Technology that improves the delivery of cannabinoids to the brain is critical to growth in the...

November 21st, 2018

Ligand Partners with iMetabolic Biopharma

The agreement will allow iMetabolic to fully access Ligand’s OmniAb therapeutic antibody platform, which includes OmniRat,...

November 21st, 2018

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time